These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 6548787

  • 1. [Evaluation of the efficacy of radiotherapy in the combined treatment of generalized Hodgkin's disease in children].
    Tsyplenkov VG, Sviridova AV.
    Med Radiol (Mosk); 1984 Oct; 29(10):34-7. PubMed ID: 6548787
    [Abstract] [Full Text] [Related]

  • 2. [3-year results of the combined treatment of stage I and II lymphogranulomatosis patients].
    Baĭsogolov GD, Shakhtarina SV.
    Med Radiol (Mosk); 1984 Apr; 29(4):46-50. PubMed ID: 6546966
    [Abstract] [Full Text] [Related]

  • 3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The combined (polychemical and radiation) and drug treatment of lymphogranulomatosis patients with generalized lung involvement (stage IV)].
    Baĭsogolov GD, Shakhtarina SV, Afanasova NV.
    Med Radiol (Mosk); 1991 Sep; 36(8):4-7. PubMed ID: 1890940
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
    Kanaev SV, Kolygin BA, Malinin AP, Chikrizov SI.
    Vopr Onkol; 1986 Sep; 32(9):53-6. PubMed ID: 3765524
    [Abstract] [Full Text] [Related]

  • 9. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG, Pieresca C, Cavanna L, Corbella F, Vallisa D, Federico M, Formisano R, Carotenuto M, Merli F, Callea V, Angrilli F, Silingardi V.
    Haematologica; 1996 Sep; 81(6):503-12. PubMed ID: 9009437
    [Abstract] [Full Text] [Related]

  • 10. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.
    Hudson MM, Krasin M, Link MP, Donaldson SS, Billups C, Merchant TE, Kun L, Billet AL, Kaste S, Tarbell NJ, Howard S, Friedmann AM, Hurwitz CA, Young JA, Marcus KC, Rai S, Cowan T, Weinstein HJ.
    J Clin Oncol; 2004 Nov 15; 22(22):4541-50. PubMed ID: 15542805
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
    Baĭsogolov GD, Afanasova NV, Shakhtarina SV.
    Med Radiol (Mosk); 1990 May 15; 35(5):10-3. PubMed ID: 2342405
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An approach to reduce treatment and invasive staging in childhood Hodgkin's disease: the sequence of the German DAL multicenter studies.
    Schellong G, Brämswig JH, Schwarze EW, Wannenmacher M.
    Bull Cancer; 1988 May 15; 75(1):41-51. PubMed ID: 3282575
    [Abstract] [Full Text] [Related]

  • 14. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, Boissevain F, De Wit M, Mezger J, Duhmke E, Willich N, Muller RP, Schmidt BF, Renner H, Muller-Hermelink HK, Pfistner B, Wolf J, Hasenclever D, Loffler M, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 Oct 01; 21(19):3601-8. PubMed ID: 12913100
    [Abstract] [Full Text] [Related]

  • 15. [The diagnosis and treatment of lymphogranulomatosis in children].
    Atamanov IuA, Malikov AA, Golovkina NM, Romantsova LA, Silinskaia NV.
    Vopr Onkol; 1991 Oct 01; 37(9-10):988-91. PubMed ID: 1842663
    [Abstract] [Full Text] [Related]

  • 16. [Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
    Kanaev SV, Kolygin BA, Malinin AP, Chikrizov SI.
    Med Radiol (Mosk); 1987 May 01; 32(5):13-5. PubMed ID: 3586916
    [Abstract] [Full Text] [Related]

  • 17. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A, Hardan I, Shpilberg O, Raanani P, Grotto I, Ben-Bassat I.
    Harefuah; 2000 Sep 01; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [Abstract] [Full Text] [Related]

  • 18. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 19. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Gobbi PG, Levis A, Chisesi T, Broglia C, Vitolo U, Stelitano C, Pavone V, Cavanna L, Santini G, Merli F, Liberati M, Baldini L, Deliliers GL, Angelucci E, Bordonaro R, Federico M, Intergruppo Italiano Linfomi.
    J Clin Oncol; 2005 Dec 20; 23(36):9198-207. PubMed ID: 16172458
    [Abstract] [Full Text] [Related]

  • 20. [The combined therapy of stage-II lymphogranulomatosis: the effect of splenectomy and the time period for achieving full remission on treatment efficacy].
    Demina EA, Kondrat'eva NF, Pirogova NA.
    Ter Arkh; 1991 Dec 20; 63(7):40-4. PubMed ID: 1788806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.